Action 1548 GENSCRIPT BIOTECH CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Genscript Biotech Corporation

Actions

1548

KYG3825B1059

Marché Fermé - Hong Kong S.E.
Autres places de cotation
 10:08:06 30/04/2024 		Varia. 5j. Varia. 1 janv.
11,64 HKD -1,02% Graphique intraday de Genscript Biotech Corporation +5,63% -41,39%
23/04 Multiply Labs et GenScript Biotech Corporation collaborent pour automatiser la phase d'isolement et d'enrichissement des cellules dans la fabrication de thérapies cellulaires CI
12/04 Genscript Biotech Corporation annonce des nominations au conseil d'administration et un changement dans la composition du comité du conseil d'administration CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
GenScript Biotech Releases 2023 ESG Report, Deepening Green Development Practices, Constructing Sustainable Future Blueprint
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission
Genscript Biotech's Unit Logs $157 Million in Q1 Sales of Blood Cancer Drug
GenScript Biotech officially joins SBTi to fulfill its sustainability commitment
Genscript Biotech Corporation Announces Directorate Appointments and Change in Composition of Board Committee
Genscript Biotech Unit's Refractory Multiple Myeloma Drug Gets FDA Approval
GenScript Biotech Receives EcoVadis Bronze Medal for Outstanding Sustainability Performance
Genscript Biotech's US Unit Secures FDA Nod for Anti-Cancer Medication
Genscript Biotech Issues 444,598 Shares to Three Grantees Under Restricted Share Scheme
Genscript Biotech's 2023 Loss Widens; Misses Revenue Estimates
Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Genscript Announces Appointment of Dr. David R. Liu to the Scientific Advisory Board
Immunotherapy Pioneer Carl H. June, MD, Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy in Advancing Cell and Gene Therapy Breakthroughs
GenScript Biotech Corporation Expands Collaboration with Roche
GenScript Announces Its Inaugural Life Science Research Grant Project
Genscript Biotech Unit Rakes in $159 Million in Sales for Myeloma Treatment; Shares Rise 4%
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 1548
  4. Actualités Genscript Biotech Corporation
  5. Autres langues